Literature DB >> 15683363

The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation.

Sandra Milasta1, Nicholas A Evans, Laura Ormiston, Shelagh Wilson, Robert J Lefkowitz, Graeme Milligan.   

Abstract

The orexin-1 receptor interacts with beta-arrestin-2 in an agonist-dependent manner. In HEK-293T cells, these two proteins became co-internalized into acidic endosomes. Truncations from the C-terminal tail did not prevent agonist-induced internalization of the orexin-1 receptor or alter the pathway of internalization, although such mutants failed to interact with beta-arrestin-2 in a sustained manner or produce its co-internalization. Mutation of a cluster of three threonine and one serine residue at the extreme C-terminus of the receptor greatly reduced interaction and abolished co-internalization of beta-arrestin-2-GFP (green fluorescent protein). Despite the weak interactions of this C-terminally mutated form of the receptor with beta-arrestin-2, studies in wild-type and beta-arrestin-deficient mouse embryo fibroblasts confirmed that agonist-induced internalization of this mutant required expression of a beta-arrestin. Although without effect on agonist-mediated elevation of intracellular Ca2+ levels, the C-terminally mutated form of the orexin-1 receptor was unable to sustain phosphorylation of the MAPKs (mitogen-activated protein kinases) ERK1 and ERK2 (extracellular-signal-regulated kinases 1 and 2) to the same extent as the wild-type receptor. These studies indicate that a single cluster of hydroxy amino acids within the C-terminal seven amino acids of the orexin-1 receptor determine the sustainability of interaction with beta-arrestin-2, and indicate an important role of beta-arrestin scaffolding in defining the kinetics of orexin-1 receptor-mediated ERK MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683363      PMCID: PMC1134986          DOI: 10.1042/BJ20041745

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs.

Authors:  Koichi Seta; Masakatsu Nanamori; J Gregory Modrall; Richard R Neubig; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2002-01-03       Impact factor: 5.157

2.  beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.

Authors:  Akira Tohgo; Kristen L Pierce; Eric W Choy; Robert J Lefkowitz; Louis M Luttrell
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

3.  Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference.

Authors:  Seungkirl Ahn; Christopher D Nelson; Tiffany Runyan Garrison; William E Miller; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

Review 4.  Regulation of G protein-coupled receptor signaling by scaffold proteins.

Authors:  Randy A Hall; Robert J Lefkowitz
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

5.  A pH-sensitive fluor, CypHer 5, used to monitor agonist-induced G protein-coupled receptor internalization in live cells.

Authors:  E J Adie; S Kalinka; L Smith; M J Francis; A Marenghi; M E Cooper; M Briggs; N P Michael; G Milligan; S Game
Journal:  Biotechniques       Date:  2002-11       Impact factor: 1.993

Review 6.  High-content assays for ligand regulation of G-protein-coupled receptors.

Authors:  Graeme Milligan
Journal:  Drug Discov Today       Date:  2003-07-01       Impact factor: 7.851

7.  The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction.

Authors:  Jessica L DeGraff; Vsevolod V Gurevich; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

8.  The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.

Authors:  Akira Tohgo; Eric W Choy; Diane Gesty-Palmer; Kristen L Pierce; Stephane Laporte; Robert H Oakley; Marc G Caron; Robert J Lefkowitz; Louis M Luttrell
Journal:  J Biol Chem       Date:  2002-12-06       Impact factor: 5.157

9.  Effective information transfer from the alpha 1b-adrenoceptor to Galpha 11 requires both beta/gamma interactions and an aromatic group four amino acids from the C terminus of the G protein.

Authors:  Sen Liu; Juan J Carrillo; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

10.  Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Huijun Wei; Seungkirl Ahn; Sudha K Shenoy; Sadashiva S Karnik; László Hunyady; Louis M Luttrell; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

View more
  30 in total

1.  Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.

Authors:  Tian-Rui Xu; Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

2.  Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

Review 4.  G-protein-coupled receptor phosphorylation: where, when and by whom.

Authors:  A B Tobin
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

5.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

6.  beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity.

Authors:  Ivo Quack; L Christian Rump; Peter Gerke; Inga Walther; Tobias Vinke; Oliver Vonend; Thomas Grunwald; Lorenz Sellin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

7.  Arachidonic acid release mediated by OX1 orexin receptors.

Authors:  Pauli M Turunen; Marie E Ekholm; Pentti Somerharju; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

8.  Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.

Authors:  L L Ferrari; L J Agostinelli; M J Krashes; B B Lowell; T E Scammell; E Arrigoni
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

9.  Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors.

Authors:  Martina Perin; Fabio Longordo; Christine Massonnet; Egbert Welker; Anita Lüthi
Journal:  J Physiol       Date:  2014-08-01       Impact factor: 5.182

Review 10.  Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling.

Authors:  Andrew B Tobin; Adrian J Butcher; Kok Choi Kong
Journal:  Trends Pharmacol Sci       Date:  2008-07-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.